Tamanna Prashar - 01 Mar 2022 Form 4 Insider Report for Lucira Health, Inc.

Reporting relationship: Vice President
Issuer ticker: N/A
Reported as of: 01 Mar 2022
Net transaction value: -$7,133
SEC form: 4
Accepted by SEC: 12 Jul 2022, 18:25:57 UTC
Prior SEC filing: 14 Feb 2022
Source filing: View source filing
Reporting owner signature: /s/ Dan George, Attorney-in-Fact for Tamanna Prashar

Key filing fact

Tamanna Prashar filed Form 4 for Lucira Health, Inc. on 12 Jul 2022.

Key facts

This page summarizes Tamanna Prashar's Form 4 filing for Lucira Health, Inc..
3 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 12 Jul 2022, 18:25.

Change

Previous filing in this sequence was filed on 14 Feb 2022.
Current net transaction value: -$7,133.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LHDXQ transaction

Common Stock

Sale

Transaction value: $6,033
Shares: -1,289
Change %: -1.1%
Price: $4.68^*
Shares after: 117,899
Date: 01 Mar 2022
Ownership: Direct
Footnotes: F1, F2

LHDXQ transaction

Common Stock

Sale

Transaction value: $475
Shares: -257
Change %: -0.22%
Price: $1.85^*
Shares after: 117,642
Date: 01 Jun 2022
Ownership: Direct
Footnotes: F1

LHDXQ transaction

Common Stock

Sale

Transaction value: $625
Shares: -248
Change %: -0.21%
Price: $2.52^*
Shares after: 117,394
Date: 08 Jul 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on March 10, 2021 for 11,475 shares.

Footnote F2

Includes 1,470 shares and 2,552 shares acquired by the reporting person under the Issuer's 2021 Employee Stock Purchase Plan on August 20, 2021 and February 20, 2022, respectively.